.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for incorporation of individuals along with MASLD as well as measurement of liver end results in cardio-- renal-- metabolic trials, when records recommend mechanistically possible advantages as well as medical security-- as well as outlines factors to consider for trial design and also governing approval.